08247 中生北控生物科技
按盘价 
0.690 -0.010 (-1.429%) | 2023/12 - 末期 人民币() | 2022/12 人民币() | 2021/12 人民币() | 2020/12 人民币() | 2019/12 人民币() | |
| 经营活动之现金流量 | (6,560,000) | 44,529,000 | 48,894,000 | 11,373,000 | 31,351,000 |
| 投资活动之现金流量 | (17,700,000) | (1,117,000) | (5,778,000) | (15,943,000) | 51,333,000 |
| 融资活动之现金流量 | 10,249,000 | (10,756,000) | (44,022,000) | 20,498,000 | (71,124,000) |
| 现金及等同现金之增加/(减少) | (14,011,000) | 32,656,000 | (906,000) | 15,928,000 | 11,560,000 |
| 期初之现金及现金等价物 | 77,349,000 | 44,469,000 | 45,453,000 | 30,052,000 | 18,208,000 |
| 汇率变动之影响 | 72,000 | 224,000 | (78,000) | (527,000) | 284,000 |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | 63,410,000 | 77,349,000 | 44,469,000 | 45,453,000 | 30,052,000 |
| 备注： | 实时报价更新时间为17/06/2024 10:38 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -11,648,000 |
| 增长率 | -- |
| 每股盈利/(亏损) | RMB -0.080 |
| 每股账面资产净值 (¥) | RMB 1.454 |